Using nutrigenomics to evaluate apoptosis as a preemptive target in cancer prevention

Current Cancer Drug Targets

Volumn 7, Issue 5, 2007, Pages 438-446

  Martin, Keith R ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Bioactive agent; DNA methylation; Epigenomics; Histone; Metabolomics; Nutrigenetics; Proteomoics; Transcriptomics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOCHROME P450; GLUTATHIONE PEROXIDASE; HISTONE; MESSENGER RNA;

APOPTOSIS; BIOCHEMISTRY; BIOLOGY; CANCER PREVENTION; CANCER STAGING; CARCINOGENESIS; CELL DEATH; DIETARY INTAKE; DNA METHYLATION; DNA POLYMORPHISM; FOOD COMPOSITION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN GENOME; METABOLOMICS; NONHUMAN; NUTRIGENOMICS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REVIEW; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS;

ANIMALS; APOPTOSIS; FOOD; GENE TARGETING; GENOMICS; HUMANS; NEOPLASMS;

EID: 34547585669     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800907781386650     Document Type: Review

References (112)

1. Forman, M.; Hursting, S.; Umar, A.; Barrett, J. Nutrition and Cancer Prevention: A Multidisciplinary Perspective on Human Trials. Annu. Rev. Nutr. 2004, 24, 223-254.
2. Willett, W. Diet, Nutrition, and Avoidable Cancer. Environ. Health Perspect. 1995, 103, 165-170.
3. Peto, R.; Doll, R.; Buckley, J.; Sporn, M. Can Dietary Beta Carotene Materially Reduce Human Cancer Rates? Nature 1981, 290, 201-208.
4. Davis, C.; Milner, J. Frontiers in Nutrigenomics, Proteomics, Metabolomics, and Cancer Prevention. Mutat. Res. 2004, 551, 51-64.
5. Go, V.; Nguyen, C.; Harris, D.; Lee, W. Nutrient-Gene Interaction" Metabolic Genotype-Phenotype Relationships. J. Nutr. 2005, 135, 3016S-3020S.
6. Trujillo, E.; Davis, C.; Milner, J. Nutrigenomics, Proteomics, Metabolomics, and the Practice of Dietetics J. Am. Dietetics Assoc. 2006, 106, 403-413.
7. Reed, J.; Pellecchia, M. Apoptosis-Based Therapies for Hematologic Malignancies. Blood 2005, 106, 408-418.
8. Finley, J. Proposed Criteria for Assessing the Efficacy of Cancer Reduction by Plant Foods Enriched in Carotenoids, Glucosinolates, Polyphenols, and Selenocompounds. Ann. Botany 2005, 95, 1075-1096.
9. Milner, J. Functional Foods: The US Perspective. Am. J. Clin. Nutr. 2000, 71, 1654S-1659S.
10. Sun, S.; Hail, N.; Lotan, R. Apoptosis as a Novel Target for Cancer Chemoprevention. J. Natl. Cancer Inst. 2004, 96, 662-672.
11. Danial, N.; Korsmeyer, S. Cell Death: Critical Control Points. Cell 2004, 116, 205-219.
12. Lockshin, R.; Zakeri, Z. Apoptosis, Autophagy, and More. Int. J. Biochem. Cell Biol. 2004, 36, 2405-2419.
13. Salveson, G.; Duckett, C. IAP Proteins: Blocking the Road to Death's Door. Nat. Rev. Mol. Cell Biol. 2002, 3, 401-410.
14. Perik, P.; de Vries, E.; Gietema, J.; van der Graaf, W.; Sleijfer, D.; Suurmeijer, A.; Van Veldhuisen, D. The Dilemma of the Strive for Apoptosis in Oncology. Crit. Rev. Oncol. Hematol. 2005, 53, 101-13.
15. Wargovich, M.; Cunningham, J. Diet, Individual Responsiveness and Cancer Prevention. J. Nutr. 2003, 133, 2400S-2403S.
16. Molloy, A. Role of Genetic Variation in Establishing Nutritional Requirements: Folate, a Case in Point. World Rev. Nutr. Diet. 2001, 89, 68-75.
17. Davis, C.; Hord, N. Nutritional "Omics" Technologies for Elucidating the Role(s) of Bioactive Food Compoennets in Colon Cancer Prevention. J. Nutr. 2005, 135, 2694-2697.
18. Agrelo, R.; Cheng, W. H.; Setien, F.; Ropero, S.; Espada, J.; Fraga, M. F.; Herranz, M.; Paz, M. F.; Sanchez-Cespedes, M.; Artiga, M. J.; Guerrero, D.; Castells, A.; von Kobbe, C.; Bohr, V. A.; Esteller, M. Epigenetic Inactivation of the Premature Aging Werner Syndrome Gene in Human Cancer. Proc. Natl. Acad. Sci. USA 2006, 103, 8822-8827.
19. Chen, C.; King, A. Dietary Cancer-Chemopreventive Compounds: from Signaling and Gene Expression to Pharmacological. TRENDS Mol. Med. 2005, 26, 318-328.
20. Aboul-Fadl, T. Selenium Derivatives as Cancer Preventive Agents. Curr. Med. Chem. Anticancer Agents 2005, 5, 637-652.
21. Rayman, M. Selenium in Cancer Prevention: A Review of the Evidence and Mechanism of Action. Proc. Nutr. Soc. 2005, 64, 527-542.
22. Diwadkar-Navsariwala, V.; Diamond, A. The Link between Selenium abd Chemoprevention: A Case for Selenoproteins. J. Nutr. 2004, 134, 2899-2902.
23. Combs, G. Chemopreventive Mechanisms of Selenium. Med. Klin. 1999, 94, 18-24.
24. Lee, E.; Min, H.; Park, H.; Chung, H.; Kim, S.; Han, Y.; Lee, S. G2/M Cell Cycle Arrest and Induction of Apoptosis by a Stilbenoid, 3,4,5-Trimethoxy-4′-bromo-cis-stilbene, in Human Lung Cancer Cells. Life Sci. 2004, 75, 2829-2839.
25. Jiang, C.; Wang, Z.; Lu, J. Distinct Effects of Methylseleninic Acid Versus Selenite on Apoptosis, Cell Cycle, and Protein Kinase Pathways in DU-145 human prostate cancer cells. Mol. Cancer Ther. 2002, 1, 1059-1066.
26. Bernhardt, R. Cytochromes P450 as Versatile Biocatalysts. J. Biotechnol. 2006, 124, 128-145.
27. Milner, J. Molecular Targets for Bioactive Food Components. J. Nutr. 2004, 134, 2492S-2498S.
28. Thornalley, P. Isothiocyanates: Mechanism of Cancer Chemopreventive Action. Anticancer Drugs 2002, 13, 331-338.
29. Sinnett, D.; Labuda, D.; Krajinovic, M. Challenges Identifying Genetic Determinants of Pediatric Cancers: The Childhood Leukemia Experience. Fam. Cancer 2006, 5, 35-47.
30. Jang, H.; Mason, J.; Choi, S. Genetic and Epigenetic Interactions between Folate and Aging in Carcinogenesis. J. Nutr. 2005, 135, 2967S-2971S.
31. Smith, P.; Syed, N.; Crook, T. Epigenetic Inactivation Implies a Tumor Suppressor Function in Hematologic Malignancies for Polo-Like Kinase but Not Polo-Like Kinase 3. Cell Cycle 2006, 5, 1262-1264.
32. Galm, O.; Wilop, S.; Luders, C.; Lost, E.; Gehbauer, G.; Herman, J.; Osieka, R. Clinical Implications of Aberrant DNA Methlyation Patterns in Acute Myelogenous Leukemia. Ann. Hematol. 2005, 84, 39-46.
33. Gopisetty, G.; Ramachandran, K.; Singal, R. DNA Methylation and Apoptosis. Mol. Immunol. 2006, 43, 1729-1740.
34. Suzuki, H.; Toyota, M.; Sato, H.; Sonoda, T.; Sakauchi, F.; Mori. M. Roles and Causes of Abnormal DNA Methylation in Gastrointestinal Cancers. Asian Pac. J. Cancer Prev. 2006, 7, 177-185.
35. Baylin, S.; DNA Methylation and Gene Silencing in Cancer. Nat. Clin. Pract. Oncol. 2005, 2, 4-11.
36. Waterland, R.; Jirtle, R. Early Nutrition, Epigenetic Changes at Transposons and Imprinted Genes, and Enhanced Susceptibility to Adult Chronic Diseases. Nutrition 2004, 20, 63-68.
37. Cooney, C.; Dave, A.; Wolff, G. Maternal Methyl Supplements in Mice Affect Epigenetic Variation and DNA Methylation of Offspring. J. Nutr. 2002, 132, 2393S-2400S.
38. Cao, D.; Sun, W.; Ou, X.; Yu, Q.; Yu, T.; Zhang, Y.; Wu, Z.; Xue, Q.; Cheng, Y. Effects of Folic Acid on Epithelial Apoptosis and Expression of Bcl-2 and p53 in Premalignant Gastric Lesions. World J. Gastroenterol. 2005, 11, 1571-1576.
39. Jackson-Grusby, L.; Beard, C.; Possemato, R.; Tudor, M.; Fambrough, D.; Csankovszki, G.; Dausman, J.; Lee, P.; Wislon, C.; Lander, E.; Jaenisch, R. Loss of Genomic Methylation Causes p53-Dependent Apoptosis and Epigenetic Deregulation. Nat. Genet. 2001, 27, 31-39.
40. Kong, W. J.; Zhang, S.; Guo, C.; Wang, W.; Chen, X.; Zhang, S. L.; Zhang, D.; Liu, Z.; Kong, W. Effect of Methylation-Associated Silencing of the Death-Associated Protein Kinases Gene on Nasopharyngeal Carcinomas. Anticancer Drugs 2006, 17, 251-259.
41. Anjum, R.; Boux, P.; Ballif, B.; Gygi, S.; Blenis, J. The Tumor Suppressor DAP Kinase is a Target of RSK-Mediated Survival Signaling. Curr. Biol. 2005, 15, 1762-1767.
42. Bialik, S.; Kimchi, A. DAP-Kinase as a Target for Drug Design in Cancer and Diseases Assocaited with Accelerated Cell Death. Semin. Cancer Biol. 2004, 14, 283-294.
43. Davis, C.; Uthus, E. DNA Methylation, Cancer Susceptibility, and Nutrient Interactions. Exp. Biol. Med. 2004, 229, 988-995.
44. Mittal, A.; Piyathilake, C.; Hara, Y.; Katiyar, S. Exceptionally High Protection of Photocarcinogenesis by Topical Application of (-)- Epigallocatechin-3-gallate in Hydrophilic Cream in SKH-1 Hairless Mouse Model: Relationship to Inhibition of UVB-Induced Global DNA Hypomethylation. Neoplasia 2003, 5, 555-565.
45. Adhami, V.; Ahmad, N.; Mukhtar, H. Molecular Targets for Rgeent tea in Prostate Cancer Prevention. J. Nutr. 2003, 133, 2417S-2424S.
46. Shimizu, M.; Weinstein, I. Modulation of Signal Transduction by Tea Catechins and Related Phytochemicals. Mutat. Res. 2005, 591, 147-160.
47. Na, H.; Surh, Y. Intracellular Signaling Network as a Prime Chemopreventive Target of (-)-Epigallocatechin Gallate. Mol. Nutr. Food Res. 2006, 50, 152-159.
48. Sarkar, F.; Li, Y. Cell Signaling Pathways Altered by Natural Chemopreventive Agents. Mutat. Res. 2004, 555, 53-64.
49. Hassan, Y.; Zempleni, J. Epigenetic Regulation of Chromatin Structure and Gene Function by Biotin. J. Nutr. 2006, 136, 1763-1765.
50. Petrelli, F.; Coderoni, S.; Moretti, P.; Paparelli, M. Effect of Biotin on Phosphorylation, Acetylation, Methylation of Rat Liver Histones. Mol. Biol. Rep. 1978, 4, 87-92.
51. Oommen, A.; Griffin, J.; Sarath, G.; Zempleni, J. Roles for Nutrients in Epigenetic Events. J. Nutr. Biochem. 2005, 16, 74-77.
52. Mai, A.; Massa, S.; Rotili, D.; Cerbara, I.; Valente, S.; Pezzi, R.; Simeoni, S.; Ragno, R. Histone Deacetylation in Epigenetics: An Attractive Target for Anticancer Therapy. Med. Res. Rev. 2005, 25, 261-309.
53. Park, J.; Jung, Y.; Kim, T.; Kim, S.; Jong, H.; Lee, J.; Kim, D.; Lee, J.; Kim, M.; Kim, T.; et al.: Class 1 Histone Deacetylase-Selective Novel Synthetic Inhibitors Potently Inhibit Humor Tumor Proliferation. Clin. Cancer Res. 2004, 10, 5271-5281.
54. Louis, M.; Rosato, R.; Brault, L.; Osbild, S.; Battaglia, E.; Yang, X.; Grant, S.; Bagrel, D. The Histone Deacetylase Inhibitor Sodium Butyrate Induces Breast Cancer Cell Apoptosis Through Diverse Cytotoxic Actions Including Glutathione Depletion and Oxidative Stress. Int. J. Oncol. 2004, 25, 1701-1711.
55. Rahmani, M.; Reese, E.; Dai, Y.; Bauer, C.; Payne, S.; Dent, P.; Spiegel, S.; Grant, S. Coadministration of Histone Deacetylase Inhibitors and Perifosine Synergistically Induces Apoptosis in Human Leukemia Cells through Akt and ERK1/2 Inactivation and the Generation of Ceramide and Reactive Oxygen Species. Cancer Res. 2005, 65, 2422-2432.
56. Myzak, M.; Dashwood, R. Histone Deacetylases as Targets for Dietary Cancer Preventive Agents: Lessons Learned with Butyrate, Diallyl Disulfide, and Sulforaphane. Curr. Drug Targets 2006, 7, 443-452.
57. Myzak, M.; Ho, E.; Dashwood, R. Dietary Agents as Histone Deacetylase Inhibitors. Mol. Carcinog. 2006, 45, 443-446.
58. Gamet-Payrastre, L. Signaling Pathways and Intracellular Targets of Sulforaphane Mediating Cell Cycle Arrest and Apoptosis. Curr. Cancer Drug Targets 2006, 6, 135-145.
59. Dashwood, R.; Myzak, M.; Ho, E. Dietary HDAC Inhibitors: Time to Rethink Waek Ligands in Cancer Chemoprevention? Carcinogenesis 2006, 27, 344-349.
60. Berardi, P.; Russell, M.; El-Ostra, A.; Riabowol, K. Functional Links between Transcription, DNA Repair, and Apoptosis. Cell Mol. Life Sci. 2004, 61, 2173-2180.
61. Smith, M. T.; Vermeulen, R.; Li, G.; Zhang, L.; Lan, Q.; Hubbard, A. E.; Forrest, M. S.; McHale, C.; Zhao, X.; Gunn, L.; Shen, M.; Rappaport, S. M.; Yin, S.; Chanock, S.; Rothman, N. Use of "Omic" Technologies to Study Humans Exposed to Benzene. Chem. Biol. Interact. 2005, 153-154, 123-127.
62. Narayanan, B.; Narayanan, N.; Stoner, G.; Bullock, B. Interactive Gene Expression Pattern in Prostate Cancer Cells Exposed to Phenolic Antioxidants. Life Sci. 2002, 70, 1821-1839.
63. Afman, L.; Muller, M. Nutrigenomics: From Molecular Nutrition to Prevention of Disease. J. Am. Dietetics Assoc. 2006, 106, 569-576.
64. Martin, K. Targeting Apoptosis with Dietary Bioactive Agents. Exp. Biol. Med. 2006, 231, 117-129.
65. van Breda, S.; van Agen, E.; van Sanden, S.; Burzykowski, T.; Kleinjans, J.; Delft, J. Vegetables Affect the Expression of Genes Involved in Carcinogenic and Anticarcinogenic Processes in the Lungs of Female C57BL/6. J. Nutr. 2005 135, 2546-2552.
66. Thompson, H.; Zhu, Z.; Jiang, W. Identification of the Apoptosis Activation Cascade Induced in Mammary Carcinomas by Energy Restriction. Cancer Res. 2004, 64, 1541-1545.
67. Li, Y.; Che, M.; Bhagat, S.; Ellis, K.; Kucuk, O.; Doerge, D. R.; Abrams, J.; Cher, M.; Sarkar, F. Regulation of Gene Expression and Inhibition of Experimental Prostate Cancer Bone Metastasis by Dietary Genistein. Neoplasia 2004, 6, 354-363.
68. Marks, L.; Kojima, M.; Demarzo, A.; Heber, D.; Bostwick, D.; Qian, J.; Dorey, F.; Veltri, R.; Mohler, J.; Partin, A. Prostate Cancer in Native Japanese and Japanese-American Men: Effects of Dietary Differences on Prostatic Tissue. Urology 2004, 64, 765-771.
69. Uematsu, F.; Takahashi, M.; Yoshida, M.; Igarashi, M.; Watanabe, N.; Suzuki, N.; Abe, M.; Rusyn, I.; Floyd, R.; Nakae, D. Distinct Patterns of Gene Expression in Hepatocellular Carcinomas and Adjacent Non-Cancerous, Cirrhotic Liver Tissues in Rats Fed a Choline-Deficient, L-Amino Acod-Defined Diet. Cancer Sci. 2005, 96, 414-424.
70. Uddin, R.; Singh, S. Ethanol-Responsive Genes: Identification of Transcription Factors and their Role in Metabolomics. Pharmacogenomics J. 2007, 7(1), 38-47.
71. Sarkar, F.; Li, Y. Indole-3-carbinol and Prostate Cancer. J. Nutr. 2004, 134, 3493S-3498S.
72. Dorai, T.; Aggarwal, B. Role of Chemopreventive Agents in Cancer Therapy. Cancer Lett. 2004, 215, 129-140.
73. Biswal, S.; Datta, K.; Shaw, S.; Feng, X.; Robertson, J.; Kehrer, J. Glutathione Oxidation and Mitochondrial Depolarization as Mechanisms of Nordihydroquaiaretic Acid-Induced Apoptosis in Lipoxygenase-Deficient Cells. Toxicol. Sci. 2000, 53, 77-83.
74. Mihara, M.; Erster, S.; Zaika, A.; Petrenko, O.; Chittenden, T.; Pancoska, P.; Moll, U. p53 has a Direct Apoptogenic Role at the Mitochondria. Mol. Cell 2003, 577-590.
75. Gupta, S.; Afaq, F.; Mukhtar, H. Involvement of nuclear Factor-kappa B, Bax, and Bcl-2 in Induction of Cell Cycle Arrest and Apoptosis by Apigenin in Human Prostate Carcinoma Cells. Oncogene 2002, 21, 3727-3738.
76. Levine, A. p53, The Cellular Gatekeeper for Growth and Division. Cell 1997, 88, 323-331.
77. Calvo, K.; Liotta, L.; Petricoin, E. Clinical Proteomics: from Biomarker Discovery and Cell Signaling Profiles to Individualized Personal Therapy. Biosci. Rep. 2005, 25, 107-125.
78. Roemer, K.; Mahyar-Roemer, M. The Basis for the Chemopreventive Action of Resveratrol. Drugs Today 2002, 38, 571-580.
79. Manna, S.; Sah, N.; Newman, R.; Cisneros, A.; Aggarwal, B. Oleandrin Suppresses the Activation of Nuclear Transcription Factor-kB, Activator Protein-1, and c-Jun N-Termianl Kinase. Cancer Res. 2000, 60, 3838-3847.
80. Manna, S.; Mukhopadhyay, A.; Aggarwal, B. Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-kB, Activator Protein-1, and Apoptosis. J. Immunol. 2000, 164, 6509-6519.
81. Ashikawa, K.; Majumbar, S.; NBanerjee, S.; Bharti, A.; Shishodia, S.; Aggarwal, B. Piceatannol Inhibits TNF-Induced NF-kB Activation and NF-kB Mediated Gene Expression through Suppression of IkappaBalpha Kinase and p65 Phosphorylation. J. Immunol. 2002, 169, 6490-6497.
82. Galati, G.; O'Brien, P. Potential Toxicity of Flavonoids and other Dietary Phenolics: Significance for their Chemopreventive and Anticancer Properties. Free Radic. Biol. Med. 2004, 37, 287-303.
83. Ueda, S.; Makamura, H.; Masutani, H.; Sasada, T.; Takabayashi, A.; Yamaoka, Y.; Yodoi, J. Baicilin Induces Apoptosis via Mitochondrial Pathway as Pro-oxidant. Mol. Pharmacol. 2001, 38, 781-791.
84. Baliga, M.; Meleth, S.; Katiyar, S. Growth Inhibitory and Antimetastatic Effect of Green Tea Polyphenols on Metastasis-Specific Mouse Mammary Carcinoma 4T1 Cells in vitro and in vivo Systems. Clin. Cancer Res. 2005, 11, 1918-1927.
85. Palozza, P.; Serini, S.; Torsello, A.; Di Nicuolo, F.; Maggiano, N.; Ranelletti, F.; Wolf, F.; Calviello, G. Mechanism of Activation of Caspase Cascade during Beta Carotene-Induced Apoptosis in Human Tumor Cells. Nutr. Cancer 2003, 47, 76-87.
86. Hantz, H.; Young, L.; Martin, K. Physiologically Attainable Concentrations of Lycopene Induce Mitochondrial Apoptosis in LNCaP Human Prostate Cancer Cells. Exp. Biol. Med. 2005, 230, 171-179.
87. Young, L.; Hantz, H.; Martin, K. Resveratrol Modulates Gene Expression Associated with Apoptosis, Proliferation, and Cell Cycle in Cells with Mutated Human c-Ha-ras, but does not Alter c-Ha-ras mRNA or Protein Expression. J. Nutr. Biochem. 2005, 16(11), 663-674.
88. Dhanalakshmi, S.; Singh, R.; Agarwal, C.; Agarwal, R. Silibinin Inhibts Constitutive and TNF Alpha-induced Activation of NF-kB and Sensitizes Human Prostate Carcinoma DU145 Cells to TNF Alpha-induced Apoptosis. Oncogene 2002, 21, 1759-1767.
89. Manson, M. Cancer Prevention-the Potential for Diet to Modulate Molecular Signalling. TRENDS Mol. Med. 2003, 9, 11-18.
90. Aggarwal, B.; Ichikawa, H. Molecular Targets and Anticancer Potential of Indole-3-carbinol and its Derivatives. Cell Cycle 2005, 4(9), 1201-1215.
91. Billard, C.; Izard, J.; Roman, V.; Kern, C.; Mathiot, C.; Meritz, F.; Kolb, J. Comparative Antiproliferative and Apoptotic Effects of Resveratrol, Epsiolnviniferin, and Vine-shots Derived Polyphenols (Vineatrols) on Chronic B Lymphocytic Leukemia Cells and Normal Human Lymphocytes. Leuk. Lymphoma 2002, 43, 1991-2002.
92. Li, Y.; Upadhyay, S.; Bhuiyan, M.; Sarkar, F. Induction of Apoptosis in Breast Cancer Cells MDA-MB-231 by Genistein. Oncogene 1999, 18, 3166-3172.
93. Wu, X.; Kassie, F.; Mersch-Sundermann, V. Induction of Apoptosis in Tumor Cells by Naturally Occurring Sulfur-Containing Compounds. Mutat. Res. 2005, 589, 81-102.
94. Ding, Y.; Chen, Z.; Liu, S.; Che, D.; Vetter, M.; Chang, C. Inhibition of Nox-4 Activity by Plumbagin, a Plant-derived Bioactive Naphthoquinone. J. Pharm. Pharmacol. 2005, 57, 111-116.
95. Huang, D.; Shen, Y.; Wu, C.; Huang, Y.; Kung, F.; Teng, C.; Guh, J. Investigation of Extrinsic and Intrinsic Apoptosis Pathways of New Clerodane Diterpenoids in Human Prostate Cancer in PC-3 Cells. Eur. J. Pharmacol. 2004, 503, 17-24.
96. Ferry-Dumazet, H.; Garnier, O.; Mamani-Matsuda, M.; Vercauteren, J.; Belloc, F.; Billiard, C.; Dupouy, M.; Thiolat, D.; Kolb, J. P.; Marit, G.; Reiffers, J.; Mossalayi, M. D. Resveratrol Inhibits the Growth and Induces the Apoptosis of both Normal and Leukemic Hematopoietic Cells. Carcinogenesis 2002, 23, 1327-1333.
97. Ulrich, S.; Wolter, F.; Stine, J. Molecular Mechanisms of the Chemopreventive Effects of Resveratrol and its Analogs in Carcinogenesis. Mol. Nutr. Food Res. 2005, 49, 452-461.
98. Zhang, Y. Cancer-Preventive Isothiocyanates: Measurement if Human Exposure Aned Mechanism of Action. Mutat. Res. 2004, 555, 173-190.
99. de Graauw, M.; Hensbergen, P.; van de Water, B. Phospho-Proteomic Analysis of Cellular Signaling. Electrophoresis 2006, 27, 2676-2686.
100. Cummings, J.; Ward, T.; Ranson, M.; Dive, C. Apoptosis Pathway-Targeted Drugs-from the Bench to the Clinic. Biochim. Biophys. Acta 2004, 1705, 53-66.
101. Bouralexis, S.; Findlay, D.; Evdokiou, A. Death to the Bad Guys: Targeting Cancer via Apo2L/TRAIL. Apoptosis 2005, 10, 35-51.
102. Clement, M.; Hirpara, J.; Chwadhury, S.; Pervaiz, S. Chemopreventive Agent Resveratrol, a Natural Product Derived from Grapes, Triggers CD95 Signaling-Dependent Apoptosis in Human Tumor Cells. Blood 1998, 92, 996-1002.
103. Manson, M.; Farmer, P.; Gescher, A.; Steward, W. Innovative Agents in Cancer Prevention. Recent Results Cancer Res. 2005, 166, 257-275.
104. Chung, J.; Huang, C.; Meng, X.; Dong, Z.; Yang, C. Inhibition of Activator Protein 1 Activity and Cell Growth by Purified Green Tea and Black Tea Polyphenols in H-Ras-Transformed Cells: Structure-Activity Relationship and Mechanisms Involved. Cancer Res. 1999, 59, 4610-4617.
105. Howells, L.; Gallacher-Horley, B.; Houghton, C. Indole-3-carbinol Inhibtis Akt/PKB and Induces Apoptosis in the Human Breast Tumor Cell line MDA MB468, but not in the Nontumorigenic HBL100 Line. Mol. Cancer Ther. 2002, 1, 1161-1172.
106. Thiede, B.; Rudel, T. Proteome Analysis of Apoptotic Cells. Mass Spectrom. Rev. 2004, 23, 333-349.
107. Chen, T.; Wang, Q.; Cui, J.; Yang, W.; Shi, Q.; Hua, Z.; Ji, J.; Shen, P. Induction of Apoptosis in Mouse Liver by Microcystin-LR: a Combined Transcriptomic, Proteomic, and Simulation Strategy. Mol. Cell Proteomics 2005, 4, 958-974.
108. Stentiford, G.; Viant, M.; Ward, D.; Johnson, P.; Martin, A.; Wenbin, W.; Cooper, H.; Lyons, B.; Feist, S. Liver Tumors in Wild Flatfish: A Histopathological, Proteomic, and Metabolomic Study. OMICS 2005, 9, 281-299.
109. Mazzanti, R.; Solazzo, M.; Fantappie, O.; Elfering, S.; Pantaleo, P.; Bechi, P.; Cianchi, F.; Ettl, A.; Giulivi, C. Differential Expression Proteomics of Human Colon Cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290, G1329-G1338.
110. Sugiura, Y.; Kashiba, M.; Maruyama, K.; Hoshikawa, K.; Sasaki, R.; Saito, K.; Kimura, H.; Goda, N.; Suematsu, M. Cadmium Exposure Alters Metabolomics of Sulfur-Containing Amino Acids in Rat Testes. Antioxid. Redox Signal. 2005, 7, 781-787.
111. Heijine, W.; Lamers, R.; van Bladeren, P.; Groten, J.; van Nesselrooij, J.; Van Ommen, B. Profiles of Metabolites and Gene Expression in Rats with Chemically Induced Hepatic Necrosis. Toxicol. Pathol. 2005, 33, 425-433.
112. Griffin, J.; Blenkiron, C.; Valonen, P.; Caldas, C.; Kauppinen, R. High-Resolution Magic Angle Spinning 1H NMR Spectroscopy and Reverse Transcription-PCR Analysis of Apoptosis in a Rat Glioma. Anal. Chem. 2006, 78, 1546-1552.